companydata.dkONCONOX ApS: Financial statements 2019
CVR: 33858965
ONCONOX ApS (CVR 33858965) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK -65,962 compared with DKK -1,029,467 the year before. Equity amounted to DKK -36,769.
- Profit/Loss
- -65,962 kr.
- Equity
- -36,769 kr.
- Total Assets
- 47,345 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | - | -66 t. | -37 t. | - |
| 2018 | - | 0 | -1 mio. | 29 t. | - |
| 2017 | - | 547 t. | 393 t. | 1.1 mio. | - |
| 2016 | - | 0 | -15 t. | 995 t. | - |
| 2015 | - | - | 1.5 mio. | 1 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
ONCONOX ApS has published its annual report for 2018. Gross profit came to DKK 0, and the net result was DKK -1,029,467.
As of May 22, 2019, is registered as an owner of ONCONOX ApS with an ownership share of 100%.
As of May 21, 2019, EY Godkendt Revisionspartnerselskab has stepped down as auditor of ONCONOX ApS.
As of May 8, 2019, Mai-Britt Zocca has left the board of directors of ONCONOX ApS.
As of May 8, 2019, Ferdinando Nicoletti has left the board of directors of ONCONOX ApS.
As of May 8, 2019, Ferdinando Nicoletti is registered as director of ONCONOX ApS.
As of May 8, 2019, Mai-Britt Zocca has stepped down as director of ONCONOX ApS.
About ONCONOX ApS
ONCONOX ApS was a Danish company of the type Anpartsselskab based in Greve, founded in 2011. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is owned by Amme Pharmaceuticals, Inc.. The company has 0 employees. In 2022, the company reported a net result of DKK -40,672 compared with DKK -43,846 the year before. Equity amounted to DKK -4,305.